These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Graft versus leukemia: effect of phytohemagglutinin-stimulated and normal spleen cells on Rauscher disease. Lair SV; Lozzio BB J Natl Cancer Inst; 1974 Oct; 53(4):1165-8. PubMed ID: 4427392 [No Abstract] [Full Text] [Related]
10. Monoclonal antibodies to xenotropic and MCF murine leukemia viruses derived during the graft-versus-host reaction. Portis JL; McAtee FJ; Cloyd MW Virology; 1982 Apr; 118(1):181-90. PubMed ID: 6281969 [No Abstract] [Full Text] [Related]
11. Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression. Hirsch MS Johns Hopkins Med J Suppl; 1974; 3():177-85. PubMed ID: 4153909 [No Abstract] [Full Text] [Related]
12. Development of tumors as a result of graft-versus-host reaction. Cornelius EA Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858 [No Abstract] [Full Text] [Related]
13. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum. Kende M; Keys LD; Gaston M; Goldin A Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033 [TBL] [Abstract][Full Text] [Related]
14. Antiself suppressive (veto) activity of responder cells in mixed lymphocyte cultures. Claësson MH; Röpke C Curr Top Microbiol Immunol; 1986; 126():213-23. PubMed ID: 2941241 [No Abstract] [Full Text] [Related]
15. Autoaggressive reactions and leukemia virus infections: interrelated events in their pathogenesis. Hirsch MS; Proffitt MR; Black PH; Ellis DA Bibl Haematol; 1975; (40):319-27. PubMed ID: 240353 [TBL] [Abstract][Full Text] [Related]
16. [Participation of phytohemagglutinin-transformed mouse lymphocytes in development of the "graft-versus-host" reaction]. Nesterenko VG; Koval'chuk LV Biull Eksp Biol Med; 1976 Sep; 82(9):1096-8. PubMed ID: 11013 [TBL] [Abstract][Full Text] [Related]
17. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity. Maier T; Holda JH; Claman HN J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774 [TBL] [Abstract][Full Text] [Related]
18. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect. Ilan Y; Margalit M; Ohana M; Gotsman I; Rabbani E; Engelhardt D; Nagler A Hum Immunol; 2005 Mar; 66(3):231-40. PubMed ID: 15784461 [TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity to antigens associated with endogenous murine C-type leukemia viruses. Hirsch ME; Kelly AP; Proffitt MR; Black PH Science; 1975 Mar; 187(4180):959-61. PubMed ID: 167435 [TBL] [Abstract][Full Text] [Related]
20. Graft-versus-host reaction in F 1 recipients in the absence of donor (parental) cell proliferation. Scollay RG; Hofman F; Globerson A Eur J Immunol; 1974 Jul; 4(7):490-3. PubMed ID: 4153366 [No Abstract] [Full Text] [Related] [Next] [New Search]